/
The challenges of using in-vitro tests for Vaccine The challenges of using in-vitro tests for Vaccine

The challenges of using in-vitro tests for Vaccine - PowerPoint Presentation

tatiana-dople
tatiana-dople . @tatiana-dople
Follow
351 views
Uploaded On 2018-11-20

The challenges of using in-vitro tests for Vaccine - PPT Presentation

Matching 20152016 Abdelghani Abid BinTarif Bob J Statham Anna B Ludi Donald P King FMD Reference Laboratory The Pirbright Institute is the OIE FAO and EU Reference Laboratory for footandmouth disease FMD The Serum Assay Unit carries out vaccine mat ID: 731084

pools vaccine wrl reference vaccine pools reference wrl match samples submitted field matching show 2016 results laboratory fmd strains

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "The challenges of using in-vitro tests f..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

The challenges of using in-vitro tests for Vaccine Matching (2015-2016)

Abdelghani (Abid) Bin-Tarif | Bob J. Statham | Anna B. Ludi | Donald P. King

FMD Reference LaboratorySlide2

The Pirbright

Institute is the OIE, FAO and EU Reference Laboratory for foot-and-mouth disease (FMD). The Serum Assay Unit carries out vaccine matching tests for international samples received by the World Reference Laboratory (WRL), to characterise the antigenic relationship (r1-value) between circulating field strains and vaccine.IntroductionSamples processing stepsSlide3

More than 195 samples submitted to WRL-FMD between submitted between Jan.2015-Oct 2016 from 27 different countries.

Samples submitted to WRL-FMD2015-2016Slide4

Serotype A:

33 field isolates have been tested by VNT from five different pools, results show good match with the vaccine strains in pools 1 and 5, but show poor match in pools 3, 4 and 6.The new lineage G-VII in pool 1 has a poor match against all vaccine viruses available in the SAU.Serotype O: 60 field isolates have been tested by VNT from five different pools. Results show good match with the vaccine strains in all pools.

Results Slide5

Future

In the future the WRL along with international reference laboratories of the OIE/FAO Network is working to harmonise and improve the robustness and repeatability of the vaccine-matching test.Acknowledgements

Don King, Anna Ludi,

Bob Statham, Ginette

Wilsden and Clare Browning

Central Service Unit (CSU)World Reference Lab (WRL)

You for submitting samples

Vaccine companies for supplying reagents

and

EuFMD

for allowing me to present

Many Thanks

.